1. | What is the prevalence of methicillin resistant Staphylococcus aureus (MRSA) in the |
 | community and what are the risk factors for its acquisition? |
2. | In frail older adults with influenza, do neuraminidase inhibitors reduce influenza- |
 | related complications? |
3. | Among older adults living in the community, what are most effective strategies for |
 | optimizing antibiotic prescribing? |
4. | What is the burden of illness due to infections in older adults living in the community? |
5. | What is the incidence and etiology of community acquired pneumonia in older adults? |
6. | What do healthcare providers and policy makers perceive to be barriers to |
 | implementation of home care agency vaccination programs? |
7. | Do nutritional supplementation strategies prevent community acquired infection in |
 | older adults? |
8. | Are alternative and complementary medicine therapies effective in preventing and |
 | treating infections in older adults? |
9. | What is the burden of illness due to infections in older adults receiving home care and |
 | what strategies are effective in preventing these infections? |
10. | What are the barriers to influenza and pneumococcus vaccination in older adults? |
11. | What are the most effective strategies to combat misinformation regarding risks of |
 | pneumococcal and influenza immunization? |
12. | Does a feeding and positioning strategy for community-based neurologically impaired |
 | older adults reduce the risk for pneumonia? |
13. | How can the diagnosis of community-acquired respiratory infections be improved in |
 | older adults? |